Baxion
Screening
Tags
Alerts
Theme
Atea Pharmaceuticals, Inc.
AVIR
·
NASDAQ
·
$4.53
Share Price as of 11/2
·
$363M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/12/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/05/26
10-Q
Q3 ended 09/30/25
11/12/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Results of Operations
08/12/26
8-K
Shareholder Vote Results
06/22/26
8-K
Current report
05/12/26
8-K
Results of Operations
03/05/26
8-K
Results of Operations
01/08/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/07/25
S-3
Shelf registration
11/07/24
POS AM
Post-effective amendment
05/10/22
POS AM
Post-effective amendment
03/01/22
POSASR
Prospectus / registration
02/28/22
Proxies
Filter
DEF 14A
Definitive proxy
04/27/26
DEFA14A
Additional proxy materials
04/27/26
DEF 14A
Definitive proxy
04/29/25
DEFA14A
Additional proxy materials
04/03/25
DEFA14A
Additional proxy materials
04/01/25
Ownership
Filter
SC 13G
Beneficial ownership
10/06/26
Form 4
Insider transaction
06/23/26
Form 4
Insider transaction
06/23/26
Form 4
Insider transaction
06/23/26
Form 4
Insider transaction
06/23/26
Other
Filter
EFFECT
Request for effectiveness
11/19/24
CORRESP
Correspondence with the SEC
11/15/24
UPLOAD
Letter from the SEC
11/14/24
ARS
Annual report to shareholders
04/28/23
EFFECT
Request for effectiveness
05/12/22
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/12/26
8-K
Results of Operations
08/12/26
8-K
Shareholder Vote Results
06/22/26
10-Q
Q1 ended 03/31/26
05/12/26
8-K
Current report
05/12/26
Ownership
Filter
SC 13G
Beneficial ownership
10/06/26
Form 4
Insider transaction
06/23/26
Form 4
Insider transaction
06/23/26
Form 4
Insider transaction
06/23/26
Form 4
Insider transaction
06/23/26